159 related articles for article (PubMed ID: 31391828)
1. Knowing the scope of meningococcal disease in Latin America.
Sáfadi MAP; Valenzuela MT; Carvalho AF; De Oliveira LH; Salisbury DM; Andrus JK
Rev Panam Salud Publica; 2017; 41():e118. PubMed ID: 31391828
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.
de Moraes JC; Perkins BA; Camargo MC; Hidalgo NT; Barbosa HA; Sacchi CT; Landgraf IM; Gattas VL; Vasconcelos Hde G
Lancet; 1992 Oct; 340(8827):1074-8. PubMed ID: 1357461
[TBL] [Abstract][Full Text] [Related]
3. The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations.
Sáfadi MA; O'Ryan M; Valenzuela Bravo MT; Brandileone MC; Gorla MC; de Lemos AP; Moreno G; Vazquez JA; López EL; Taha MK; Borrow R;
Vaccine; 2015 Nov; 33(48):6529-36. PubMed ID: 26597036
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention.
Sáfadi MA; Cintra OA
Neurol Res; 2010 Apr; 32(3):263-71. PubMed ID: 20406604
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
Noronha CP; Struchiner CJ; Halloran ME
Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
[TBL] [Abstract][Full Text] [Related]
6. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.
Villena R; Safadi MAP; Valenzuela MT; Torres JP; Finn A; O'Ryan M
Hum Vaccin Immunother; 2018 May; 14(5):1042-1057. PubMed ID: 29667483
[TBL] [Abstract][Full Text] [Related]
7. A consensus statement: meningococcal disease among infants, children and adolescents in Latin America.
Rüttimann RW; Gentile A; Parra MM; Saez-Llorens X; Safadi MA; Santolaya ME
Pediatr Infect Dis J; 2014 Mar; 33(3):284-90. PubMed ID: 24463807
[TBL] [Abstract][Full Text] [Related]
8. The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative.
Sáfadi MA; de los Monteros LE; López EL; Sàez-Llorens X; Lemos AP; Moreno-Espinosa S; Ayala SG; Torres JP; de Moraes JC; Vázquez JA
Expert Rev Vaccines; 2013 Aug; 12(8):903-15. PubMed ID: 23909747
[TBL] [Abstract][Full Text] [Related]
9. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
10. An overview of meningococcal disease in India: knowledge gaps and potential solutions.
John TJ; Gupta S; Chitkara AJ; Dutta AK; Borrow R
Vaccine; 2013 Jun; 31(25):2731-7. PubMed ID: 23588082
[TBL] [Abstract][Full Text] [Related]
11. Evolving meningococcal immunization strategies.
Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
[TBL] [Abstract][Full Text] [Related]
12. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis.
Presa JV; de Almeida RS; Spinardi JR; Cane A
Int J Infect Dis; 2019 Mar; 80():137-146. PubMed ID: 30641200
[TBL] [Abstract][Full Text] [Related]
15. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.
Atkinson B; Gandhi A; Balmer P
Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease.
Watson PS; Turner DP
Vaccine; 2016 Feb; 34(7):875-80. PubMed ID: 26686570
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of infant meningococcal disease in the United States, 2006-2012.
MacNeil JR; Bennett N; Farley MM; Harrison LH; Lynfield R; Nichols M; Petit S; Reingold A; Schaffner W; Thomas A; Pondo T; Mayer LW; Clark TA; Cohn AC
Pediatrics; 2015 Feb; 135(2):e305-11. PubMed ID: 25583921
[TBL] [Abstract][Full Text] [Related]
18. Meningococcal disease: risk for international travellers and vaccine strategies.
Wilder-Smith A
Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
[TBL] [Abstract][Full Text] [Related]
19. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
Yezli S
Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
[TBL] [Abstract][Full Text] [Related]
20. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations.
Baker CJ
J Adolesc Health; 2016 Aug; 59(2 Suppl):S29-37. PubMed ID: 27449147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
